CollPlant Biotechnologies Ltd. Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Equity (Details Textual 1)

Equity (Details Textual 1) ₪ / shares in Units, $ / shares in Units, ₪ in Thousands, $ in Thousands											1 Months Ended	12 Months Ended
	Dec. 07, 2017 ₪ / shares shares	Aug. 22, 2017 ILS (₪) $ / shares shares	Aug. 15, 2016 shares	Jul. 31, 2016 $ / shares	Aug. 31, 2015 ILS (₪) shares	Aug. 31, 2015 ILS (₪) $ / shares	Jun. 24, 2015 ILS (₪) $ / shares shares	May 21, 2015 $ / shares shares	May 18, 2015 ILS (₪) $ / shares shares	Mar. 22, 2015 $ / shares shares	Jul. 30, 2015 ILS (₪) ₪ / shares	Dec. 31, 2017 ILS (₪) shares	Dec. 31, 2017 USD ($)	Dec. 31, 2016 ILS (₪) shares	Dec. 31, 2015 ILS (₪) shares	Aug. 22, 2017 $ / shares	Aug. 31, 2015 USD ($) $ / shares	Jul. 30, 2015 $ / shares	May 18, 2015 $ / shares
Equity (Textual)
Approved grant options			3,620,885				92,045			10,000,000
Options to purchase of ordinary shares			235,413				30,682			3,333,333
Options vest periods										5 years
Option exercise price \| $ / shares				$ 0.8			$ 0.30			$ 0.6
Fair value of general meeting approval options \| ₪							$ 27				₪ 4,758
Grant date fair value of options \| ₪ / shares											₪ 0.48
Expected dividend rate											0.00%
Expected volatility rate											56.49%
Risk-free interest rate											2.00%
Expected term											4 years
Share-based compensation to employees and consultants												₪ 4,970	$ 1,433	₪ 3,572	₪ 4,081
Options exercisable												20,922,506		14,350,118	11,700,665
Total unrecognized compensation cost of stock options \| ₪												₪ 5,200
Unrecognized compensation cost of employee stock options is expected to be recognized.												4 years	4 years
CEO [Member]
Equity (Textual)
Approved grant options									5,670,000
Options to purchase of ordinary shares									1,890,000
Options vest periods									4 years
Option exercise price \| $ / shares									$ 0.60
Fair value of general meeting approval options \| ₪											₪ 2,698
Grant date fair value of options \| $ / shares																		$ 0.48
Expected dividend rate											0.00%
Expected volatility rate											56.49%
Risk-free interest rate											2.00%
Expected term											4 years
Employees and Officers [Member]
Equity (Textual)
Approved grant options									7,450,000
Options to purchase of ordinary shares									2,483,333
Options vest periods									4 years
Option exercise price \| $ / shares									$ 0.60
Fair value of general meeting approval options \| ₪									$ 1,597
Grant date fair value of options \| $ / shares																			$ 0.22
Expected dividend rate									0.00%
Expected volatility rate									56.18%
Risk-free interest rate									2.00%
Expected term									4 years
Consultant [Member]
Equity (Textual)
Approved grant options									1,000,000
Options to purchase of ordinary shares									333,333
Option exercise price \| $ / shares									$ 0.60
Fair value of general meeting approval options \| ₪									$ 240
Four Board Members [Member]
Equity (Textual)
Approved grant options								2,680,000
Options to purchase of ordinary shares								893,333
Options to purchase of ordinary shares to each								670,000
Options vest periods								4 years
Option exercise price \| $ / shares								$ 0.60
Fair value of general meeting approval options \| ₪											₪ 1,275
Grant date fair value of options \| $ / shares																		$ 0.48
Expected dividend rate											0.00%
Expected volatility rate											56.49%
Risk-free interest rate											2.00%
Expected term											4 years
Two New Officers [Member]
Equity (Textual)
Approved grant options					1,300,000
Options to purchase of ordinary shares					433,333
Options vest periods					4 years
Option exercise price \| $ / shares						$ 0.85
Fair value of general meeting approval options \| ₪					₪ 331	$ 331
Grant date fair value of options \| $ / shares																	$ 0.25
Expected dividend rate					0.00%
Expected volatility rate					56.36%
Risk-free interest rate					2.00%
Expected term					4 years
One Director [Member]
Equity (Textual)
Approved grant options		486,000
Options to purchase of ordinary shares		486,000
Options granted		221,000
Option exercise price \| $ / shares		$ 0.33
Fair value of general meeting approval options \| ₪		$ 99
Grant date fair value of options \| $ / shares																$ 0.13
Expected dividend rate		0.00%
Expected volatility rate		60.53%
Risk-free interest rate		2.00%
Expected term		4 years
Options exercisable		265,000
Fair value of each option share price \| $ / shares		$ 0.29
Officers and Employees [Member]
Equity (Textual)
Approved grant options					9,100,000
Options to purchase of ordinary shares					9,100,000
Option granted value \| ₪					₪ 2,145
Options vest periods					1 year
Option exercise price \| ₪ / shares	₪ 0.58
Fair value of general meeting approval options \| $
Grant date fair value of options \| $ / shares
Expected dividend rate					0.00%
Expected volatility rate					61.96%
Risk-free interest rate					2.00%
Expected term					4 years
Shareholder [Member]
Equity (Textual)
Approved grant options	6,900,000
Options to purchase of ordinary shares	6,900,000